Efficacy News and Research

RSS
Gilead commences GS-7340 Phase 2 trial in HIV

Gilead commences GS-7340 Phase 2 trial in HIV

Covidien releases results of TurboHawk and SpiderFX combination study on P.A.D.

Covidien releases results of TurboHawk and SpiderFX combination study on P.A.D.

ImmunoCellular initiates enrollment in ICT-107 Phase II trial for GBM in 23 centers

ImmunoCellular initiates enrollment in ICT-107 Phase II trial for GBM in 23 centers

Baxter to commence second GAMMAGARD LIQUID Phase III trial in Alzheimer's

Baxter to commence second GAMMAGARD LIQUID Phase III trial in Alzheimer's

Takeda receives FDA approval for VELCADE sNDA to treat MM

Takeda receives FDA approval for VELCADE sNDA to treat MM

PLC Systems initiates enrollment in RenalGuard pivotal trial for CIN

PLC Systems initiates enrollment in RenalGuard pivotal trial for CIN

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Charité coordinates largest study in the world against common childhood cancer

Charité coordinates largest study in the world against common childhood cancer

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

Risperdal lawsuit settlement: Largest Medicaid fraud case in Texas

Risperdal lawsuit settlement: Largest Medicaid fraud case in Texas

Awake ECMO may be an effective bridging strategy for lung transplantation candidates

Awake ECMO may be an effective bridging strategy for lung transplantation candidates

Combination of gefitinib and miRNA-inhibitor might effectively treat NSCLC

Combination of gefitinib and miRNA-inhibitor might effectively treat NSCLC

Banner Alzheimer's Institute presents results from Navidea AZD4694 study at 6th Annual HAI

Banner Alzheimer's Institute presents results from Navidea AZD4694 study at 6th Annual HAI

FDA issues complete response letter to Bristol-Myers Squibb and AstraZeneca's dapagliflozin

FDA issues complete response letter to Bristol-Myers Squibb and AstraZeneca's dapagliflozin

Experimental drug helps patients with advanced colon cancer

Experimental drug helps patients with advanced colon cancer

Proceedings from Workshop on Effective Use of Fluoride in Asia

Proceedings from Workshop on Effective Use of Fluoride in Asia

Interprofessional seminar on teamwork in medicine

Interprofessional seminar on teamwork in medicine

Biotectix announces FIH use of electrostimulation device with BT DOT polymer coatings

Biotectix announces FIH use of electrostimulation device with BT DOT polymer coatings

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Live interactive consultations can improve clinical outcomes for patients

Live interactive consultations can improve clinical outcomes for patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.